OptimizeRx Corp — Director's Dealing 2016

Feb 25, 2016

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2016-02-22

Reporting Person: FEBBO WILLIAM J (Chief Executive Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	9433	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option	$1.07	2021-02-28	Common Stock (1500000)		Direct

Footnotes

F1: The option vests in 20% increments annually on each of the first, Second, third, fourth and fifth anniversaries of February 22, 2016.